"Pneumonia, Pneumocystis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
| Descriptor ID |
D011020
|
| MeSH Number(s) |
C01.703.534.700 C01.703.770.700 C08.381.472.700 C08.381.677.675 C08.730.435.700 C08.730.610.675
|
| Concept/Terms |
Pneumonia, Pneumocystis- Pneumonia, Pneumocystis
- Pneumocystis Pneumonias
- Pneumocystis jirovecii Pneumonia
- Pneumonia, Pneumocystis jirovecii
- Pneumocystosis
- Pneumocystoses
- Pneumocystis Pneumonia
- Pneumocystis carinii Pneumonia
- Pneumonia, Pneumocystis carinii
- PCP Infection
- Infection, PCP
- PCP Infections
- Pneumonia, Interstitial Plasma Cell
|
Below are MeSH descriptors whose meaning is more general than "Pneumonia, Pneumocystis".
Below are MeSH descriptors whose meaning is more specific than "Pneumonia, Pneumocystis".
This graph shows the total number of publications written about "Pneumonia, Pneumocystis" by people in this website by year, and whether "Pneumonia, Pneumocystis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pneumonia, Pneumocystis" by people in Profiles.
-
Huang YC, Lee NY, Weng MY. Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor. J Microbiol Immunol Infect. 2025 Feb; 58(1):112-119.
-
Cao B, Robinson JE, Winget M, Hunt MH, Carlson R, Hogan SL, Derebail VK, Thorpe CT. Infection prophylaxis among patients with antineutrophil cytoplasmic antibody (ANCA) vasculitis: a scoping review. Clin Rheumatol. 2024 Sep; 43(9):2765-2781.
-
Sahu KK, Mishra AK, Lal A, Siddiqui AD, George SV. Methemoglobinemia: a challenge while managing pneumocystis jirovecii pneumonia. N Z Med J. 2020 05 08; 133(1514):88-89.
-
Bolduc P, Roder N, Colgate E, Cheeseman SH. Care of Patients With HIV Infection: Medical Complications and Comorbidities. FP Essent. 2016 Apr; 443:16-22.
-
Yoon C, Subramanian A, Chi A, Crothers K, Meshnick SR, Taylor SM, Beard CB, Jarlsberg LG, Lawrence GG, Avery M, Swartzman A, Fong S, Roth B, Huang L. Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort. Med Mycol. 2013 Aug; 51(6):568-75.
-
Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation. Clin Transplant. 2012 May-Jun; 26(3):E184-90.
-
Mu?oz C, Zuluaga A, Restrepo A, Tob?n A, Cano LE, Gonzalez A. Molecular diagnosis and detection of Pneumocystis jirovecii DHPS and DHFR genotypes in respiratory specimens from Colombian patients. Diagn Microbiol Infect Dis. 2012 Mar; 72(3):204-13.
-
Davaro RE, Thirumalai A. Life-threatening complications of HIV infection. J Intensive Care Med. 2007 Mar-Apr; 22(2):73-81.
-
Huang L, Welsh DA, Miller RF, Beard CB, Lawrence GG, Fox M, Swartzman A, Bensley MR, Carbonnet D, Davis JL, Chi A, Yoo BJ, Jones JL. Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia. J Eukaryot Microbiol. 2006; 53 Suppl 1:S114-6.
-
Gebo KA, Fleishman JA, Reilly ED, Moore RD. High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States. Med Care. 2005 Sep; 43(9 Suppl):III23-30.